Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate WP_013012189.1 DACET_RS14910 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::K9RIB8 (448 letters) >NCBI__GCF_000025725.1:WP_013012189.1 Length = 426 Score = 323 bits (827), Expect = 9e-93 Identities = 178/421 (42%), Positives = 256/421 (60%), Gaps = 6/421 (1%) Query: 28 SLSGSIRVPGDKSISHRALMLGALAEGETRIEGLLLGEDPRSTAKCFQAMGALVSDLNTE 87 S+ G++RVP DKSISHR+ ML ++A+G R+ LL D ++T +A+G + Sbjct: 9 SIKGTVRVPSDKSISHRSFMLLSMAKGRGRVIDPLLSADTKATMAAMRAVGVQFEETVNG 68 Query: 88 LVRVKGIGLGNLLEPVDVLDAGNSGTTLRLMLGILASHAGRFFSITGDSSLRSRPMSRVV 147 V + G N EP DV+D NSGT+ RL+ G+ A +++ +TGD+S+R RPM RV+ Sbjct: 69 FV-ITSDGYQNFKEPSDVIDCMNSGTSARLLTGVFAP-TNKYYVLTGDNSMRKRPMDRVI 126 Query: 148 KPLEQMGAQIWGRDNNSKAPLAVRGENLKPIHYHSPIASAQVKSCVLLAGLSVEGKTTVT 207 PL +MGA+ RDN SK PL + P+ + SAQVKS +LLAG+ EG TT T Sbjct: 127 LPLTEMGAKFAARDNGSKLPLTILPSVTNPVELTASTKSAQVKSAILLAGVQTEGVTTYT 186 Query: 208 EPALSRDHSERMLQAFGAKLDIDTQTNSVSVNGPVKLYGQSVVVPGDISSAAFWLVAGAI 267 E A++R+H+E ML A GA L +D +SV G L VVVPGD SSAAF+L + Sbjct: 187 EKAVTRNHTEIMLSALGANLTVDGL--KISVEGAADLRSIDVVVPGDFSSAAFFLGGTLM 244 Query: 268 VSDSELLIENVGVNPTRTGVLEALEMMGAEIARENEREVAGEPVADLRVRSSKLKGCTIE 327 +SEL++ENVG+NPTR+G+L L MG + ++ER A E + D+ ++S +GCTI+ Sbjct: 245 FDNSELILENVGLNPTRSGMLNVLTQMGVKYEIDSERGGA-EKLGDICIKSQSFEGCTID 303 Query: 328 GDIIPRLIDEIPILAVAAVFAEGTTVIKDAAELRVKESDRITVMANQLNSMGARITELDD 387 GDI+ +IDE+P++A +FA I++A ELRVKESDRI L +GA + E +D Sbjct: 304 GDIVANMIDELPMVATLGLFANSPVTIRNAKELRVKESDRIEATLYNLRQLGAEVEEYED 363 Query: 388 GMEITGGTPLTG-AELDSFTDHRIAMSLAIAALNASGTTTINRAEAASVSYPDFFETIKR 446 GM++ + AEL +F DHR+AM + A G T++ + VS+P F ET + Sbjct: 364 GMKVYPIKSVNDKAELKAFDDHRMAMIAIMLAKRFGGNITVDDMQCVDVSFPTFIETFES 423 Query: 447 I 447 + Sbjct: 424 L 424 Lambda K H 0.316 0.132 0.363 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 453 Number of extensions: 18 Number of successful extensions: 6 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 448 Length of database: 426 Length adjustment: 32 Effective length of query: 416 Effective length of database: 394 Effective search space: 163904 Effective search space used: 163904 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.6 bits) S2: 51 (24.3 bits)
Align candidate WP_013012189.1 DACET_RS14910 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.27709.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 2.7e-117 378.0 0.3 3.1e-117 377.8 0.3 1.0 1 lcl|NCBI__GCF_000025725.1:WP_013012189.1 DACET_RS14910 3-phosphoshikimate Domain annotation for each sequence (and alignments): >> lcl|NCBI__GCF_000025725.1:WP_013012189.1 DACET_RS14910 3-phosphoshikimate 1-carboxyvinyltransferase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 377.8 0.3 3.1e-117 3.1e-117 1 412 [. 12 424 .. 12 426 .] 0.95 Alignments for each domain: == domain 1 score: 377.8 bits; conditional E-value: 3.1e-117 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakveeekeelviegvgg..lk 67 g +++p++KSishR+++l ++a+g+ +v ++L s+Dt+at+ a+r+ G+++ee+ + +vi+ g+ +k lcl|NCBI__GCF_000025725.1:WP_013012189.1 12 GTVRVPSDKSISHRSFMLLSMAKGRGRVIDPLLSADTKATMAAMRAVGVQFEETVNGFVITSDGYqnFK 80 789*************************************************9988888876655559* PP TIGR01356 68 epeaeldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlai 136 ep++++d+ nsGt+aRlltgv a +++ +vltgd+s++kRP++r++ +L e+ga++ ++++ ++lPl+i lcl|NCBI__GCF_000025725.1:WP_013012189.1 81 EPSDVIDCMNSGTSARLLTGVFAPTNKYYVLTGDNSMRKRPMDRVILPLTEMGAKFAARDNGSKLPLTI 149 ********************************************************************* PP TIGR01356 137 sgplkggivelsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeeder 205 ++ ++ + + S+Q+ksa+lla+ q++++++++ek ++r+++ei+L l++ ++++ lcl|NCBI__GCF_000025725.1:WP_013012189.1 150 LPSVTNPVELTASTKSAQVKSAILLAG---VQTEGVTTYTEKAVTRNHTEIMLSALGAN---LTVDGL- 211 *97776666667788************...6889**********************988...999876. PP TIGR01356 206 kivvkggqkykqkevevegDaSsAafflaaaaitge.evtvenlgenstqgdkaiiivLeemGadveve 273 ki+v+g + ++ +v v+gD+SsAaffl ++ + e+ +en+g n+t+ + +++vL +mG + e++ lcl|NCBI__GCF_000025725.1:WP_013012189.1 212 KISVEGAADLRSIDVVVPGDFSSAAFFLGGTLMFDNsELILENVGLNPTRSG--MLNVLTQMGVKYEID 278 *******9999999*******************9999***************..999************ PP TIGR01356 274 eqr.......dvevegasklkgvkv.didvdsliDelptlavlaafAegetriknieelRvkEsdRiaa 334 ++r d+ ++ +++++g ++ v+++iDelp++a+l++fA+ + +i+n++elRvkEsdRi+a lcl|NCBI__GCF_000025725.1:WP_013012189.1 279 SERggaeklgDICIK-SQSFEGCTIdGDIVANMIDELPMVATLGLFANSPVTIRNAKELRVKESDRIEA 346 ***************.678******66889*************************************** PP TIGR01356 335 iaeeLeklGveveeledgllieGkkkelkg.avvdtydDHRiamalavlglaaegeveiedaecvaksf 402 + +L++lG+evee edg+++++ k ++++ a+++ +dDHR+am +l+ + g+++++d +cv++sf lcl|NCBI__GCF_000025725.1:WP_013012189.1 347 TLYNLRQLGAEVEEYEDGMKVYPIK-SVNDkAELKAFDDHRMAMIAIMLAKRFGGNITVDDMQCVDVSF 414 ************************6.66555************************************** PP TIGR01356 403 PeFfevleql 412 P F+e e+l lcl|NCBI__GCF_000025725.1:WP_013012189.1 415 PTFIETFESL 424 *****99987 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (426 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.00s 00:00:00.01 Elapsed: 00:00:00.01 # Mc/sec: 10.03 // [ok]
This GapMind analysis is from Apr 10 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory